Influence of urban/rural and coastal/inland environment on the prevalence, phenotype, and clinical course of inflammatory bowel disease patients from northwest of Spain: A cross-sectional study

European Journal of Gastroenterology and Hepatology

Volumn 27, Issue 9, 2015, Pages 1030-1037

  Carpio, Daniel ^a   Barreiro De Acosta, Manuel ^b   Echarri, Ana ^c   Pereira, Santos ^d   Castro, Javier ^c   Ferreiro, Rocio ^b   Lorenzo, Aurelio ^b  

^a Instituto de Investigación Sanitaria Galicia Sur   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^c Universidad de La Coruña   (Spain)

^d UNIVERSITY HOSPITAL COMPLEX OF VIGO   (Spain)

Author keywords

coast; Crohn's disease; epidemiology; inflammatory bowel disease; inland; risk factors; rural; ulcerative colitis; urban

Indexed keywords

CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; STEROID; TUMOR NECROSIS FACTOR INHIBITOR;

ADULT; AGE; ARTICLE; CLINICAL FEATURE; CORTICOSTEROID THERAPY; CROHN DISEASE; CROSS-SECTIONAL STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG DEPENDENCE; FAMILY HISTORY; FEMALE; GEOGRAPHIC AND GEOLOGICAL PHENOMENA; HIGH RISK POPULATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY BOWEL DISEASE; INLAND AREA; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; RURAL AREA; SEASHORE; SEX RATIO; SMOKING; SPAIN; ULCERATIVE COLITIS; URBAN AREA; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; COLITIS, ULCERATIVE; COMPARATIVE STUDY; DEMOGRAPHY; ENVIRONMENT; HEALTH; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; ODDS RATIO; PROGNOSIS; PROTECTION; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL;

ADULT; CHI-SQUARE DISTRIBUTION; COLITIS, ULCERATIVE; CROHN DISEASE; CROSS-SECTIONAL STUDIES; ENVIRONMENT; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREVALENCE; PROGNOSIS; PROTECTIVE FACTORS; RESIDENCE CHARACTERISTICS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; RURAL HEALTH; SEVERITY OF ILLNESS INDEX; SPAIN; URBAN HEALTH;

EID: 84938940037     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0000000000000395     Document Type: Article

References (76)

1. Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet 2007; 369: 1627-1640
2. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998; 115: 182-205
3. Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med 2009; 361: 2066-2078
4. Binder V. Epidemiology of IBD during the twentieth century: an integrated view. Best Pract Res Clin Gastroenterol 2004; 18: 463-479
5. Blanchard JF, Bernstein CN, Wajda A, Rawsthorne P. Small-Area variations and sociodemographic correlates for the incidence of Crohn's disease and ulcerative colitis. Am J Epidemiol 2001; 154: 328-335
6. Shanahan F, Bernstein CN the evolving epidemiology of inflammatory bowel disease. Curr Opin Gastroenterol 2009; 25: 301-305
7. Bengtson MB, Aamodt G, Vatn MH, Harris JR. Concordance for IBD among twins compared to ordinary siblings-A Norwegian populationbased study. J Crohns Colitis 2010; 4: 312-318
8. Thia KT, Loftus EV Jr, Sandborn WJ, Yang SK. An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol 2008; 103: 3167-3182
9. Tsironi E, Feakins RM, Probert CS, Rampton DS, Phil D. Incidence of inflammatory bowel disease is rising and abdominal tuberculosis is falling in Bangladeshis in East London, United Kingdom. Am J Gastroenterol 2004; 99: 1749-1755
10. Williams CN. Does the incidence of IBD increase when persons move from a low-To a high-risk area? Inflamm Bowel Dis 2008; 14 (Suppl 2): S41-S42
11. Danese S, Sans M, Fiocci C. Inflammatory bowel disease: the role of environmental factors. Autoimmun Rev 2004; 3: 394-400
12. Lashner BA. Epidemiology of inflammatory bowel disease. Gastroenterol Clin North Am 1995; 24: 467-474
13. Nerich V, Monnet E, Etienne A, Louafi S, Ramée C, Rican S, et al. Geographical variations of inflammatory bowel disease in France: a study based on national health insurance data. Inflamm Bowel Dis 2006; 12: 218-226
14. Bernstein CN. Epidemiologic clues to inflammatory bowel disease. Curr Gastroenterol Rep 2010; 12: 495-501
15. Benchimol EI, Fortinsky KJ, Gozdyra P, Van den Heuvel M, Van Limbergen J, Griffiths AM. Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm Bowel Dis 2011; 17: 423-439
16. Kyle J. An epidemiological study of Crohn's disease in Northeast Scotland. Gastroenterology 1971; 61: 826-833
17. Gollop JH, Phillips SF, Melton LJ 3rd, Zinsmeister AR. Epidemiologic aspects of Crohn's disease: a population based study in Olmsted County, Minnesota, 1943-1982. Gut 1988; 29: 49-56
18. Ekbom A, Helmick C, Zack M, Adami HO the epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology 1991; 100: 350-358
19. López-Serrano P, Pérez-Calle JL, Pérez-Fernández MT, Fernández-Font JM, Boixeda de Miguel D, Fernández-Rodríguez CM. Environmental risk factors in inflammatory bowel diseases. Investigating the hygiene hypothesis: a Spanish case-control study. Scand J Gastroenterol 2010; 45: 1464-1471
20. Sinclair TS, Brunt PW, Mowat NA. Nonspecific proctocolitis in northeastern Scotland: a community study. Gastroenterology 1983; 85: 1-11
21. Green C, Elliott L, Beaudoin C, Bernstein CN A population-based ecologic study of inflammatory bowel disease: searching for etiologic clues. Am J Epidemiol 2006; 164: 615-623
22. Aamodt G, Jahnsen J, Bengtson MB, Vatn MH. IBSEN Study Group. Geographic distribution and ecological studies of inflammatory bowel disease in southeastern Norway in 1990-1993. Inflamm Bowel Dis 2008; 14: 984-991
23. Klement E, Lysy J, Hoshen M, Avitan M, Goldin E, Israeli E. Childhood hygiene is associated with the risk for inflammatory bowel disease: a population-based study. Am J Gastroenterol 2008; 103: 1775-1782
24. Ekbom A, Adami HO, Helmick CG, Jonzon A, Zack MM. Perinatal risk factors for inflammatory bowel disease: a case-control study. Am J Epidemiol 1990; 132: 1111-1119
25. Norlen BJ, Krause U, Bergman L. An epidemiological study of Crohn's disease. Scand J Gastroenterol 1970; 5: 385-390
26. Kugathasan S, Judd RH, Hoffmann RG, Heikenen J, Telega G, Khan F, et al. Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study. J Pediatr 2003; 143: 525-531
27. Aldrey Vázquez JA the Galician population, 1900-2005 Demographic changes and territorial implications. Vigo: Ir Indo Publisher, A Fraga Universitaria collection; 2006
28. Carracedo A, Pereira G. Genetics and history in the northwest of iberian península, an interdisciplinar perspective. Santiago de Compostela: Galician Culture Council, Science, Technology and Society Section; 2005
29. Varela TA, Fariña J, Diéguez LP, Lodeiro R. Gene flow and genetic structure in the Galician population (NW Spain) according to Alu insertions. BMC Genet 2008; 9: 79
30. Van Assche G, Dignass A, Panes J, Beaugerie L, Karagiannis J, Allez M, et al the second European evidence-based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. J Crohns Colitis 2010; 4: 7-27
31. Stange EF, Travis SPL, Vermeire S, Reinisch W, Geboes K, Barakauskiene A, et al. European evidence-based consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis. J Crohns Colitis 2008; 2: 1-23
32. Armitage EL, Aldhous MC, Anderson N, Drummond HE, Riemersma RA, Ghosh S, et al. Incidence of juvenile onset Crohn's disease in Scotland: association with northern latitude and affluence. Gastroenterology 2004; 127: 1051-1057
33. Gearry RB, Richardson AK, Frampton CM, Dodgshun AJ, Barclay ML. Population-based cases control study of inflammatory bowel disease risk factors. J Gastroenterol Hepatol 2010; 25: 325-333
34. Sonnenberg A, McCarty DJ, Jacobsen SJ. Geographic variation of inflammatory bowel disease within the United States. Gastroenterology 1991; 100: 143-149
35. Maté-Jimenez J, Muñoz S, Vicent D, Pajares JM. Incidence and prevalence of ulcerative colitis and Crohn's disease in urban and rural areas of Spain from 1981 to 1988. J Clin Gastroenterol 1994; 18: 27-31
36. Molinie F, Gower-Rousseau C, Yzet T, Merle V, Grandbastien B, Marti R, et al. Opposite evolution in incidence of Crohn's disease and ulcerative colitis in Northern France (1988-1999). Gut 2004; 53: 843-848
37. Gunesh S, Thomas GA, Williams GT, Roberts A, Hawthorne AB the incidence of Crohn's disease in Cardiff over the last 75 years: an update for 1996-2005. Aliment Pharmacol Ther 2008; 27: 211-219
38. Srivastava ED, Mayberry JF, Morris TJ, Smith PM, Williams GT, Roberts GM, et al. Incidence of ulcerative colitis in Cardiff over 20 years: 1968-87. Gut 1992; 33: 256-258
39. Ananthakrishnan AN, McGinley EL, Binion DG, Saeian K. Ambient air pollution correlates with hospitalizations for inflammatory bowel disease: an ecologic analysis. Inflamm Bowel Dis 2011; 17: 1138-1145
40. Kaplan GG, Hubbard J, Korzenik J, Sands BE, Panaccione R, Ghosh S, et al the inflammatory bowel diseases and ambient air pollution: a novel association. Am J Gastroenterol 2010; 105: 2412-2419
41. Baron S, Turck D, Leplat C, Merle V, Gower-Rousseau C, Marti R, et al. Environmental risk factors in paediatric inflammatory bowel diseases: a population based case control study. Gut 2005; 54: 357-363
42. Hampe J, Heymann K, Krawczak M, Schreiber S. Association of inflammatory bowel disease with indicators for childhood antigen and infection exposure. Int J Colorectal Dis 2003; 18: 413-417
43. Radon K, Windstetter D, Poluda AL, Mueller B, von Mutius E, Koletzko S, et al. Contact with farm animals in early life and juvenile inflammatory bowel disease: a case-control study. Pediatrics 2007; 120: 354-361
44. Stratchan DP. Hay fever, hygiene, and household size. BMJ 1989; 299: 1259-1260
45. Oikonen M, Laaksonen M, Laippala P, Oksaranta O, Lilius EM, Lindgren S, et al. Ambient air quality and occurrence of multiple sclerosis relapse. Neuroepidemiology 2003; 22: 95-99
46. Hart JE, Laden F, Puett RC, Costenbader KH, Karlson EW. Exposure to traffic pollution and increased risk of rheumatoid arthritis. Environ Health Perspect 2009; 117: 1065-1069
47. Tornqvist H, Mills NL, Gonzalez M, Miller MR, Robinson SD, Megson IL, et al. Persistent endothelial dysfunction in humans after diesel exhaust inhalation. Am J Respir Crit Care Med 2007; 176: 395-400
48. Dybdahl M, Risom L, Moller P, Autrup H, Wallin H, Vogel U, et al. DNA adduct formation and oxidative stress in colon and liver of Big Blue rats after dietary exposure to diesel particles. Carcinogenesis 2003; 24: 1759-1766
49. Gibson PR, Shepherd SJ. Personal view: food for thought-western lifestyle and susceptibility to Crohn's disease the FODMAP hypothesis. Aliment Pharmacol Ther 2005; 21: 1399-1409
50. Mayberry JF, Rhodes J, Allan R, Newcombe RG, Regan GM, Chamberlain LM, et al. Diet in Crohn's disease two studies of current and previous habits in newly diagnosed patients. Dig Dis Sci 1981; 26: 444-448
51. Björkstén B, Naaber P, Sepp E, Mikelsaar M the intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin Exp Allergy 1999; 29: 342-346
52. Alm JS, Swartz J, Lilja G, Scheynius A, Pershagen G. Atopy in children of families with an anthroposophic lifestyle. Lancet 1999; 353: 1485-1488
53. Kyle J. Crohn's disease in the northeastern and northern Isles of Scotland: an epidemiological review. Gastroenterology 1992; 103: 392-399
54. Powell JJ, Harvey RS, Ashwood P, Wolstencroft R, Gershwin ME, Thompson RP. Immune potentiation of ultrafine dietary particles in normal subjects and patients with inflammatory bowel disease. J Autoimmun 2000; 14: 99-105
55. Bonnevie O A socioeconomic study of patients with ulcerative colitis. Scand J Gastroenterol 1967; 2: 129-136
56. Keighley A, Miller DS, Hughes AO, Langman MJ the demographic and social characteristics of patients with Crohn's disease in the Nottingham area. Scand J Gastroenterol 1976; 11: 293-296
57. Duggan AE, Usmani I, Neal KR, Logan RF. Appendectomy, childhood hygiene, Helicobacter pylori status, and risk of inflammatory bowel disease: a case control study. Gut 1998; 43: 494-498
58. Gent AE, Hellier MD, Grace RH, Swarbrick ET, Coggon D. Inflammatory bowel disease and domestic hygiene in infancy. Lancet 1994; 343: 766-767
59. Bernstein CN, Wajda A, Svenson LW, MacKenzie A, Koehoorn M, Jackson M, et al the epidemiology of inflammatory bowel disease in Canada: a population-based study. Am J Gastroenterol 2006; 101: 1559-1568
60. Logan RF, Kay CR. Oral contraception, smoking and inflammatory bowel disease: findings in the Royal College of General Practitioners Oral Contraception Study. Int J Epidemiol 1989; 18: 105-107
61. Jiang L, Xia B, Li J, Ye M, Yan W, Deng C, et al. Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China. Inflamm Bowel Dis 2006; 12: 212-217
62. Berner J, Kiaer T. Ulcerative colitis and Crohn's disease on the Faroe Islands 1964-83: a retrospective epidemiological survey. Scand J Gastroenterol 1986; 21: 188-192
63. Lesage S, Zouali H, Cézard JP, Colombel JF, Belaiche J, Almer S, et al. for the EPWG-IBD Group, EPIMAD Group and GETAID Group. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 2002; 70: 845-857
64. Heliö T, Halme L, Lappalainen M, Fodstad H, Paavola-Sakki P, Turunen U, et al. CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn's disease. Gut 2003; 52: 558-562
65. Annese V, Lombardi G, Perri F, D'Incà R, Ardizzone S, Riegler G, et al. Variants of CARD15 are associated with an aggressive clinical course of Crohn's disease-An IG-IBD study. Am J Gastroenterol 2005; 100: 84-92
66. Radford-Smith G, Pandeya N. Associations between NOD2/CARD15 genotype and phenotype in Crohn's disease-Are we there yet? World J Gastroenterol 2006; 12: 7097-7103
67. Cuffari C the genetics of inflammatory bowel disease: diagnostic and therapeutic implications. World J Pediatr 2010; 6: 203-209
68. Cosnes J, Carbonnel F, Carrat F, Beaugerie L, Cattan S, Gendre J. Effects of current and former cigarette smoking on the clinical course of Crohn's disease. Aliment Pharmacol Ther 1999; 13: 1403-1411
69. Lindberg E, Järnerot G, Huitfeldt B. Smoking in Crohn's disease: effect on localisation and clinical course. Gut 1992; 33: 779-782
70. Boyko EJ, Perera DR, Koepsell TD, Keane EM, Inui TS. Effects of cigarette smoking on the clinical course of ulcerative colitis. Scand J Gastroenterol 1988; 23: 1147-1152
71. Beaugerie L, Seksik P, Nion-Larmurier I, Gendre JP, Cosnes J. Predictors of Crohn's disease. Gastroenterology 2006; 130: 650-656
72. Magro F, Barreiro-de Acosta M, Lago P, Carpio D, Cotter J, Echarri A, et al. Clinical practice in Crohn's disease in bordering regions of two countries: different medical options, distinct surgical events. J Crohn Colitis 2010; 4: 301-311
73. Barreiro-de Acosta M, Magro F, Carpio D, Lago P, Echarri A, Cotter J, et al. Ulcerative colitis in northern Portugal and Galicia in Spain. Inflamm Bowel Dis 2010; 16: 1227-1238
74. Button LA, Roberts SE, Goldacre MJ, Akbari A, Rodgers SE, Williams JG. Hospitalized prevalence and 5-year mortality for IBD: record linkage study. World J Gastroenterol 2010; 16: 431-438
75. Targan SR, Landers CJ, Yang H, Lodes MJ, Cong Y, Papadakis KA, et al. Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease. Gastroenterology 2005; 128: 2020-2028
76. Macintyre S, Ellaway A. Ecological approaches: rediscovering the role of the physical and social environment. In: Berkman L, Kawchi I, editors. Social epidemiology. New York, NY: Oxford University Press; 2000. pp. 332-348